205 related articles for article (PubMed ID: 22948718)
1. Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension.
Kopkan L; Husková Z; Sporková A; Varcabová Š; Honetschlägerová Z; Hwang SH; Tsai HJ; Hammock BD; Imig JD; Kramer HJ; Bürgelová M; Vojtíšková A; Kujal P; Vernerová Z; Červenka L
Kidney Blood Press Res; 2012; 35(6):595-607. PubMed ID: 22948718
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME.
Honetschlägerová Z; Kitada K; Husková Z; Sporková A; Kopkan L; Bürgelová M; Varcabová Š; Nishiyama A; Hwang SH; Hammock BD; Imig JD; Kramer HJ; Kujal P; Vernerová Z; Červenka L
J Hypertens; 2013 Feb; 31(2):321-32. PubMed ID: 23307303
[TBL] [Abstract][Full Text] [Related]
3. Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats.
Sporková A; Jíchová S; Husková Z; Kopkan L; Nishiyama A; Hwang SH; Hammock BD; Imig JD; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Cervenka L
Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):1003-13. PubMed ID: 25224811
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
[TBL] [Abstract][Full Text] [Related]
5. Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats.
Sporková A; Kopkan L; Varcabová S; Husková Z; Hwang SH; Hammock BD; Imig JD; Kramer HJ; Cervenka L
Am J Physiol Regul Integr Comp Physiol; 2011 Jun; 300(6):R1468-75. PubMed ID: 21411763
[TBL] [Abstract][Full Text] [Related]
6. [Expression and role of soluble epoxide hydrolase in renal tissue of two kidneys one clip hypertension rats model].
Pan YJ; Tao ZF; Wang Q; Lu M; Guan YF; Zhu Y; Wang Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 43(6):820-6. PubMed ID: 22178827
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension.
Neckář J; Kopkan L; Husková Z; Kolář F; Papoušek F; Kramer HJ; Hwang SH; Hammock BD; Imig JD; Malý J; Netuka I; Ošťádal B; Červenka L
Clin Sci (Lond); 2012 Jun; 122(11):513-25. PubMed ID: 22324471
[TBL] [Abstract][Full Text] [Related]
8. N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase.
Hou HH; Hammock BD; Su KH; Morisseau C; Kou YR; Imaoka S; Oguro A; Shyue SK; Zhao JF; Lee TS
Cardiovasc Res; 2012 Jan; 93(1):120-9. PubMed ID: 22072631
[TBL] [Abstract][Full Text] [Related]
9. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
Elmarakby AA; Faulkner J; Pye C; Rouch K; Alhashim A; Maddipati KR; Baban B
Clin Sci (Lond); 2013 Oct; 125(7):349-59. PubMed ID: 23611540
[TBL] [Abstract][Full Text] [Related]
10. Dietary capsaicin-mediated attenuation of hypertension in a rat model of renovascular hypertension.
Segawa Y; Hashimoto H; Maruyama S; Shintani M; Ohno H; Nakai Y; Osera T; Kurihara N
Clin Exp Hypertens; 2020 May; 42(4):352-359. PubMed ID: 31518162
[No Abstract] [Full Text] [Related]
11. Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension.
Sigmon DH; Beierwaltes WH
Hypertension; 1998 Feb; 31(2):649-56. PubMed ID: 9461236
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis.
Deng W; Zhu Y; Lin J; Zheng L; Zhang C; Luo M
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():67-74. PubMed ID: 28822809
[TBL] [Abstract][Full Text] [Related]
13. Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension.
Honetschlägerová Z; Husková Z; Vaňourková Z; Sporková A; Kramer HJ; Hwang SH; Tsai HJ; Hammock BD; Imig JD; Červenka L; Kopkan L
J Physiol; 2011 Jan; 589(Pt 1):207-19. PubMed ID: 21078594
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.
Kujal P; Čertíková Chábová V; Škaroupková P; Husková Z; Vernerová Z; Kramer HJ; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Kitada K; Nishiyama A; Hwang SH; Hammock BD; Imig JD; Červenka L
Clin Exp Pharmacol Physiol; 2014 Mar; 41(3):227-37. PubMed ID: 24471737
[TBL] [Abstract][Full Text] [Related]
15. Endothelial nitric oxide synthase protein is reduced in the renal medulla of two-kidney, one-clip hypertensive rats.
Wickman A; Andersson IJ; Jia J; Hedin L; Bergström G
J Hypertens; 2001 Sep; 19(9):1665-73. PubMed ID: 11564988
[TBL] [Abstract][Full Text] [Related]
16. Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats.
Walkowska A; Skaroupková P; Husková Z; Vanourková Z; Chábová VC; Tesar V; Kramer HJ; Falck JR; Imig JD; Kompanowska-Jezierska E; Sadowski J; Cervenka L
J Hypertens; 2010 Mar; 28(3):582-93. PubMed ID: 19940786
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system.
Varcabova S; Huskova Z; Kramer HJ; Hwang SH; Hammock BD; Imig JD; Kitada K; Cervenka L
Clin Exp Pharmacol Physiol; 2013 Apr; 40(4):273-81. PubMed ID: 23039246
[TBL] [Abstract][Full Text] [Related]
19. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.
Revermann M; Barbosa-Sicard E; Dony E; Schermuly RT; Morisseau C; Geisslinger G; Fleming I; Hammock BD; Brandes RP
J Hypertens; 2009 Feb; 27(2):322-31. PubMed ID: 19226702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
